Arthur Przybyl is CEO & President at ANI PHARMACEUTICALS INC (ANIP). They have made 7 open-market trades across 1 company since 2016, most recently 2020-04-07.
CIK 0001023024
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANIP | 192,424 | $13.9M |
Shares reported on the most recent Form 4, priced at the 2020-04-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL | 2019-05-13 | 2019-05-15 | $70.07 | $2.1M | -2.0% | +1.2% | +3.4% |
| ANIP | SELL | 2019-03-19 | 2019-03-20 | $63.51 | $179K | +9.6% | +7.5% | +15.5% |
| ANIP | SELL | 2019-03-18 | 2019-03-20 | $63.53 | $1.6M | +9.6% | +7.5% | +15.5% |
| ANIP | SELL | 2018-03-13 | 2018-03-14 | $61.83 | $2.5M | -5.0% | -4.2% | +8.2% |
| ANIP | SELL | 2018-03-01 | 2018-03-05 | $61.23 | $1.5M | -7.0% | -7.7% | -1.2% |
| ANIP | SELL | 2016-08-22 | 2016-08-23 | $66.97 | $2.5M | -10.6% | -0.3% | -13.9% |
| ANIP | SELL | 2016-08-22 | 2016-08-23 | $66.97 | $2.5M | -10.6% | -0.3% | -13.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.